Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Divestments (2021 - 2022)

Historic Divestments for Ernexa Therapeutics (ERNA) over the last 2 years, with Q4 2022 value amounting to -$119000.0.

  • Ernexa Therapeutics' Divestments changed N/A to -$119000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$119000.0, marking a year-over-year change of. This contributed to the annual value of $119000.0 for FY2021, which is N/A changed from last year.
  • Per Ernexa Therapeutics' latest filing, its Divestments stood at -$119000.0 for Q4 2022.
  • Ernexa Therapeutics' 5-year Divestments high stood at $119000.0 for Q1 2021, and its period low was -$119000.0 during Q4 2022.